Chemoinformaics analysis of COUMARINE, 6-(7-HYDROXYCOUMARIN-8-YL)-7-METHOXY-
| Molecular Weight | 336.299 | nRot | 2 |
| Heavy Atom Molecular Weight | 324.203 | nRig | 24 |
| Exact Molecular Weight | 336.063 | nRing | 4 |
| Solubility: LogS | -5.041 | nHRing | 2 |
| Solubility: LogP | 2.882 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 20 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 22 |
| nHA | 6 | APOL | 44.5435 |
| nHD | 1 | BPOL | 18.9825 |
| QED | 0.565 |
| Synth | 2.524 |
| Natural Product Likeliness | 1.046 |
| NR-PPAR-gamma | 0.941 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.035 |
| Pgp-sub | 0.816 |
| HIA | 0.014 |
| CACO-2 | -4.795 |
| MDCK | 0.0000269 |
| BBB | 0.007 |
| PPB | 0.880497 |
| VDSS | 0.529 |
| FU | 0.0635214 |
| CYP1A2-inh | 0.951 |
| CYP1A2-sub | 0.94 |
| CYP2c19-inh | 0.188 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.181 |
| CYP2c9-sub | 0.881 |
| CYP2d6-inh | 0.714 |
| CYP2d6-sub | 0.879 |
| CYP3a4-inh | 0.663 |
| CYP3a4-sub | 0.251 |
| CL | 10.749 |
| T12 | 0.405 |
| hERG | 0.043 |
| Ames | 0.127 |
| ROA | 0.288 |
| SkinSen | 0.072 |
| Carcinogencity | 0.869 |
| EI | 0.132 |
| Respiratory | 0.091 |
| NR-Aromatase | 0.851 |
| Antiviral | Yes |
| Prediction | 0.613137 |